发明名称 VIRALLY-MEDIATED TARGETING OF DRUGS AND GENETIC MATERIAL
摘要 A method for introducing genetic material or another molecule with a therapeutic purpose into cells or organisms is disclosed. A virus, or virus component, is used to introduce the genetic material, or other molecule with a therapeutic purpose, into a living cell or organism by infection. The cell or organism is exposed to a specific inhibitor or proteasomal function, whereby the inhibitor is administered in such a way so that it exerts its inhibitory action on proteasomal function at the time that the cell or organism is infected with the virus or virus component and whereby the inhibitor causes attenuation and/or blocking of the normal proteasomal functions of degradation of viral components and blocking of infection is disclosed. The therapeutic benefits that are mediated by the virus or virus component are thereby augmented.
申请公布号 WO0009167(A1) 申请公布日期 2000.02.24
申请号 WO1999GB02739 申请日期 1999.08.13
申请人 BRIDGEHEAD TECHNOLOGIES LIMITED;POGSON, CHRISTOPHER, IAN 发明人 POGSON, CHRISTOPHER, IAN
分类号 A61K31/4015;A61K48/00;A61P31/12;(IPC1-7):A61K48/00;A61K31/40 主分类号 A61K31/4015
代理机构 代理人
主权项
地址